van Stijn Diana, Slegers Annemarie, Zaaijer Hans, Kuijpers Taco
Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Laboratory of Clinical Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Front Pediatr. 2021 Jan 21;8:627957. doi: 10.3389/fped.2020.627957. eCollection 2020.
Kawasaki Disease (KD) is a pediatric vasculitis of which the pathogenesis is unclear. The hypothesis is that genetically pre-disposed children develop KD when they encounter a pathogen which remains most often unidentified or pathogen derived factors. Since age is a dominant factor, prior immune status in children could influence their reactivity and hence the acquisition of KD. We hypothesized that systemic immune responses early in life could protect against developing KD. With this study we tested whether the incidence of previous systemic cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection is lower in children with KD compared to healthy age-matched controls. We compared 86 KD patients with an age-matched control group regarding CMV and EBV VCA IgG measurements (taken before or 9 months after IVIG treatment). We found that both CMV and EBV had an almost 2-fold lower seroprevalence in the KD population than in the control group. We suggest that an under-challenged immune system causes an altered immune reactivity which may affect the response to a pathological trigger causing KD in susceptible children.
川崎病(KD)是一种发病机制尚不清楚的儿童血管炎。其假说为,具有遗传易感性的儿童在遇到通常仍无法确定的病原体或病原体衍生因子时会患上川崎病。由于年龄是一个主要因素,儿童先前的免疫状态可能会影响其反应性,进而影响川崎病的发病情况。我们推测,生命早期的全身免疫反应可以预防川崎病的发生。在这项研究中,我们测试了与年龄匹配的健康对照组相比,川崎病患儿既往系统性巨细胞病毒(CMV)或EB病毒(EBV)感染的发生率是否更低。我们比较了86例川崎病患者与年龄匹配的对照组在CMV和EBV VCA IgG检测结果(在静脉注射免疫球蛋白治疗前或治疗后9个月进行检测)。我们发现,川崎病患者群体中CMV和EBV的血清阳性率比对照组低近两倍。我们认为,免疫系统受到的刺激不足会导致免疫反应性改变,这可能会影响易感儿童对导致川崎病的病理触发因素的反应。